Evidence map›Paper›PMID 32632529›Full record

ArticleProtein & cell2020

Rewiring ERBB3 and ERK signaling confers resistance to FGFR1 inhibition in gastrointestinal cancer harbored an ERBB3-E928G mutation.

Xiang Yang, Hongxiao Wang, Enjun Xie, Biyao Tang, Qingdian Mu, Zijun Song, Junyi Chen, Fudi Wang, Junxia Min

Open access · diamondAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Protein & cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiang YangThe First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.ORCID 0000-0002-3026-2672
Hongxiao WangThe First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.ORCID 0000-0003-1806-3483
Enjun XieThe First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.ORCID 0000-0002-5739-0404
Biyao TangThe First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.ORCID 0000-0002-9059-0045
Qingdian MuThe First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.ORCID 0000-0002-8504-2861
Zijun SongThe First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.ORCID 0000-0003-3201-0556
Junyi ChenThe First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.ORCID 0000-0002-8130-9426
Fudi WangThe First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.ORCID 0000-0001-8730-0003
Junxia MinThe First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China. junxiamin@zju.edu.cn.ORCID 0000-0001-8099-6327
Zhejiang University · CNFirst Affiliated Hospital Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, NeoplasmGastrointestinal NeoplasmsMAP Kinase Signaling SystemMutation, MissenseReceptor, ErbB-3Receptor, Fibroblast Growth Factor, Type 1Amino Acid SubstitutionAntineoplastic AgentsCell Line, TumorHumansAntineoplastic AgentsERBB3 protein, humanFGFR1 protein, humanReceptor, ErbB-3Receptor, Fibroblast Growth Factor, Type 1

Identifiers

PMID32632529
PMCPMC7719122
OpenAlexW3040524411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.